Camptothean-peptide conjugates and pharmaceutical compositions containing the same
Abstract
The present invention relates to a novel compound of use in the improved delivery of therapeutic drug agents into target cells or tissues, composition comprising the same and uses thereof. The compound is more specifically a conjugate of a peptidic moiety and a camptothecin, a derivative or analog thereof which provides numerous benefits, including enhancement in terms of aqueous solubility, pharmacokinetics and tissue distribution, enlargement of the therapeutic index, and limitation of the inter-patient metabolic variability, as well as improvement of delivery of the biologically active ingredient to the target cells or tissues.
Claims
exact text as granted — not AI-modified1 - 42 . (canceled)
43 . A pharmaceutical composition comprising a conjugate selected from the group consisting of
and a pharmaceutically acceptable carrier.
44 . The composition of claim 43 , wherein the conjugate is
45 . The composition of claim 43 , wherein the conjugate is
46 . The composition of claim 43 , wherein the conjugate isJoin the waitlist — get patent alerts
Track US2013244956A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.